Skip to content
LookupMeds

Active ingredient

Deflazacort

54 finished FDA listings contain Deflazacort as their only active ingredient.

See all listingsCompare with another medication

FDA NDC Directory

Ingredient names as written by FDA
DEFLAZACORT
Dosage forms
Suspension, Tablet
Routes
Oral
Manufacturers / labelers
11
Strengths listed
18 mg/1 · 22.75 mg/ml · 30 mg/1 · 36 mg/1 · 6 mg/1
Brand names in FDA listings
Deflazacort Oral Suspension, Emflaza, Jaythari, Jaythari Oral Suspension, Kymbee, Pyquvi

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 22396

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 208684PTC THERAP2017-02-094
NDA 208685PTC THERAP2017-02-091
ANDA 217123AUROBINDO PHARMA LTD2024-02-094
ANDA 217813TRIS PHARMA INC2024-04-251
ANDA 216720UPSHER SMITH LABS2024-11-058
ANDA 217741SUN PHARM2025-03-184
ANDA 219254ZYDUS LIFESCIENCES2025-04-0820
ANDA 219417AUCTA2025-06-301
ANDA 216992UPSHER SMITH LABS2025-08-111
ANDA 220042ZYDUS LIFESCIENCES2025-10-034
ANDA 217173AMNEAL2025-12-124
ANDA 219930SUN PHARM INDS INC2026-01-271
ANDA 220709BIOCON PHARMA2026-05-281

Official labeling on DailyMed

Showing the 12 most recent of 17 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.